TY  - JOUR
T1  - Desolvation Conditions for Production of Sulfasalazine Based Albumin Nanoparticles: Physical Properties
AU  - Olaitan, Victor 
AU  - Chaw, Cheng Shu 
PY  - 2019
N1  - doi: 10.20900/pf20190006
DO  - 10.20900/pf20190006
T2  - Pharmaceutical Frontiers
JF  - Pharmaceutical Frontiers
JO  - Pharm Front.
VL  - 1
IS  - 1
SP  - e190006
C7  - e190006
PB  - Hapres
M3  - doi: 10.20900/pf20190006
UR  - https://pf.hapres.com/htmls/PF_1069_Detail.html
ER  -